Search company, investor...
Search
Caris Life Sciences company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

carislifesciences.com

Founded Year

1996

Stage

Private Equity - II | Alive

Total Raised

$1.314B

Valuation

$0000 

Last Raised

$830M | 1 yr ago

Mosaic Score

+100 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Caris Life Sciences

Caris Life Sciences is an Irving, Texas-based provider of molecular science that assess DNA, RNA and proteins to reveal a molecular blueprint that allows physicians and cancer patients to make precise and personalized treatment decisions.

Caris Life Sciences Headquarters Location

750 W John Carpenter Fwy Suite 800

Irving, Texas, 75039,

United States

866-771-8946

ESPs containing Caris Life Sciences

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers Tech

Companies in this market provide tests that help to determine the appropriate course of treatment for a given patient based on their genomic profile. Many solutions in this space also include a software portal that enables physicians to easily navigate the data and make decisions.

Caris Life Sciences named as Leader among 13 other companies, including Tempus, PierianDx, and Genomenon.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Caris Life Sciences

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Caris Life Sciences in 3 CB Insights research briefs, most recently on Aug 22, 2022.

Expert Collections containing Caris Life Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Caris Life Sciences is included in 9 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,191 items

M

Medical Devices

8,684 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health Monitoring & Diagnostics

76 items

Companies developing companion diagnostics and technology enabling the development of companion diagnostics. Tagged as #CompanionDx

Caris Life Sciences Patents

Caris Life Sciences has filed 1 patent.

The 3 most popular patent topics include:

  • Biotechnology
  • Clusters of differentiation
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/6/2018

3/9/2021

Monoclonal antibodies, Molecular biology, Clusters of differentiation, Immunology, Biotechnology

Grant

Application Date

3/6/2018

Grant Date

3/9/2021

Title

Related Topics

Monoclonal antibodies, Molecular biology, Clusters of differentiation, Immunology, Biotechnology

Status

Grant

Latest Caris Life Sciences News

People in the News at ARPA-H, Caris Life Sciences, Fabric Genomics, More

Sep 16, 2022

Save for later ARPA-H: Renee Wegrzyn President Joe Biden has appointed Renee Wegrzyn as the first director of the Advanced Research Projects Agency for Health (ARPA-H). She will be responsible for driving the agency's research portfolio and budget. Wegrzyn comes to ARPA-H from Ginkgo Bioworks, where she was VP of business development and head of innovation at the firm's Concentric testing and biosecurity subsidiary. Prior to that, she was a program manager at the Defense Advanced Research Projects Agency (DARPA) in the Biological Technologies Office. She is a member of the scientific advisory board of the Innovative Genomics Institute and a member of the standing committee on biotechnology capabilities and national security needs of the National Academy of Sciences. Wegrzyn holds a doctorate in molecular biology and bioengineering from the Georgia Institute of Technology. Caris Life Sciences: Russ Denton Russ Denton has joined Caris Life Sciences as senior VP general counsel and secretary, leading Caris' legal and corporate governance efforts. Previously, he was a partner at Shearman & Sterling, where he worked with Caris as outside counsel in connection with the firm's growth equity financing transactions. Before that, he was a partner at Andrews Kurth Kenyon and an associate at Skadden, Arps, Slate, Meagher and Flom. Denton received a JD from Stanford Law School and a BS from Duke University. Fabric Genomics: Sean Hofherr Fabric Genomics has hired Sean Hofherr as chief commercial officer and clinical director. Hofherr, a fellow of the American College of Medical Genetics and Genomics, had been executive VP and CLIA laboratory director at GeneDx, which was acquired by Sema4 in April. Prior to that, he helped build the clinical diagnostics program at Children’s National Hospital in Washington, DC. For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.

Caris Life Sciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Caris Life Sciences Rank

  • When was Caris Life Sciences founded?

    Caris Life Sciences was founded in 1996.

  • Where is Caris Life Sciences's headquarters?

    Caris Life Sciences's headquarters is located at 750 W John Carpenter Fwy, Irving.

  • What is Caris Life Sciences's latest funding round?

    Caris Life Sciences's latest funding round is Private Equity - II.

  • How much did Caris Life Sciences raise?

    Caris Life Sciences raised a total of $1.314B.

  • Who are the investors of Caris Life Sciences?

    Investors of Caris Life Sciences include Sixth Street Partners, Neuberger Berman, Highland Capital Management, OrbiMed Advisors, T. Rowe Price and 14 more.

  • Who are Caris Life Sciences's competitors?

    Competitors of Caris Life Sciences include Perthera and 4 more.

You May Also Like

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Massive Bio Logo
Massive Bio

Massive Bio is an AI powered platform that connects cancer patients and their treating oncologists to clinical trials while enabling pharmaceutical companies to get access to patients, mostly in community practices, and their information to speed up drug development. Massive Bio provides unique tech enabled services and a big data platform that addresses all points of friction in clinical trial enrollment. Massive Bio was founded in 2014 and is based in New York, New York.

Deep 6 AI Logo
Deep 6 AI

Deep 6 AI finds patients for clinical trials in minutes rather than months. Using artificial intelligence and natural language processing on clinical data, Deep 6 AI's software accelerates patient recruitment exponentially, getting life-saving treatment to patients more quickly.

Inato Logo
Inato

Inato provides an AI-based data collection tool for the pharmaceutical sector. The tool collects and analyses data for site selection and patient recruitment in clinical trials, helping to accelerate the process and reduce development costs.

TrialJectory Logo
TrialJectory

Trialjectory is an AI-based trial matching platform that uses self-reported clinical information to facilitate clinical trial search, matching, and enrollment by cancer patients and their physicians.

Inspire Logo
Inspire

ClinicaHealth develops the website Inspire, which provides online health and wellness for patients and caregivers, in partnership with national patient advocacy organizations and helps life science organizations connect with the population.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.